WUXI NEWS

WuXi and Lilly Collaborate to Develop Novel Therapeutics in China
Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project
Congratulations to Novira Therapeutics for its Acquisition Agreement with Johnson & Johnson
---

PERSPECTIVES

Prospects for Cell and Gene Therapy: An Interview with Alan Moore, VP of Strategic Accounts and Cell Manufacturing
Meet IDSU Leadership: An Interview with Tao Guo, VP of Medicinal Chemistry
---

FDA APPROVALS AND DESIGNATIONS

---

Subscribe to our Newsletter!

Email us at communications@wuxiapptec.com for your important clinical milestones and we will share it with our community. 

---
---

Thank you for your support in helping WuXi reach where we are today. We will continue with our goal - to serve you better with our integrated technology and capability platform.
 Office of Corporate Communications, WuXi AppTec

Web: www.wuxiapptec.com/wxpress | Email: communications@wuxiapptec.com